发明授权
US5929299A Helicobacter pylori-colonized mongolian gerbils, method for preparation
thereof, and method for screening anti-Helicobacter pylori substance
using them
失效
幽门螺杆菌定殖的蒙古沙鼠,其制备方法,幽门螺杆菌分离培养基及使用它们的抗幽门螺杆菌物质筛选方法
- 专利标题: Helicobacter pylori-colonized mongolian gerbils, method for preparation thereof, and method for screening anti-Helicobacter pylori substance using them
- 专利标题(中): 幽门螺杆菌定殖的蒙古沙鼠,其制备方法,幽门螺杆菌分离培养基及使用它们的抗幽门螺杆菌物质筛选方法
-
申请号: US693100申请日: 1996-08-09
-
公开(公告)号: US5929299A公开(公告)日: 1999-07-27
- 发明人: Yoshifumi Ikeda , Fumihiro Hirayama , Shiro Takagi
- 申请人: Yoshifumi Ikeda , Fumihiro Hirayama , Shiro Takagi
- 申请人地址: JPX Osaka
- 专利权人: Yoshitomi Pharmaceutical Industries, Ltd.
- 当前专利权人: Yoshitomi Pharmaceutical Industries, Ltd.
- 当前专利权人地址: JPX Osaka
- 优先权: JPX6-308618 19941213
- 主分类号: A01K67/027
- IPC分类号: A01K67/027 ; A61K49/00 ; C12Q1/04 ; C12N5/00 ; C12N1/00 ; C12N15/00
摘要:
Helicobacter pylori-colonized Mongolian gerbils prepared by oral inoculation of a broth culture obtained from a liquid culture of Helicobacter pylori, to the Mongolian gerbils for intragastric colonization of Helicobacter pylori. These Mongolian gerbil models are useful for screening the therapeutic efficacies of drugs against Helicobacter pylori, as well as elucidation of pathology of Helicobacter pylori disease in humans. Moreover, the medium of the present invention for isolating Helicobacter pylori, which is supplemented with vancomycin, trimethoprim, amphotericin B, polymyxin B and 2,3,5-triphenyltetrazolium chloride, enables selective and efficient detection of Helicobacter pylori colonized in their Mongolian gerbils which have microorganisms living in stomach. A combined use of the above-mentioned Mongolian gerbil models and the medium for isolating Helicobacter pylori enables screening of an anti-Helicobacter pylori substance at an animal levels thereby enabling accurate prediction of clinical effects of the anti-Helicobacter pylori substance.
信息查询